Cargando…
A pilot randomized controlled trial of supervised, at-home, self-administered transcutaneous auricular vagus nerve stimulation (taVNS) to manage long COVID symptoms
BACKGROUND: Although the coronavirus disease 19 (COVID-19) pandemic has now impacted the world for over two years, the persistent secondary neuropsychiatric effects are still not fully understood. These “long COVID” symptoms, also referred to as post-acute sequelae of SARS-CoV-2 infection (PASC), ca...
Autores principales: | Badran, Bashar W, Huffman, Sarah M, Dancy, Morgan, Austelle, Christopher W, Bikson, Marom, Kautz, Steven A, George, Mark S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238186/ https://www.ncbi.nlm.nih.gov/pubmed/35765566 http://dx.doi.org/10.21203/rs.3.rs-1716096/v1 |
Ejemplares similares
-
A pilot randomized controlled trial of supervised, at-home, self-administered transcutaneous auricular vagus nerve stimulation (taVNS) to manage long COVID symptoms
por: Badran, Bashar W., et al.
Publicado: (2022) -
At-Home Telemedicine Controlled taVNS Twice Daily for 4 weeks is Feasible and Safe for Long COVID Symptoms.
por: Huffman, Sarah, et al.
Publicado: (2021) -
At-home telemedicine controlled taVNS twice daily for 4 weeks reduces long COVID symptoms of anxiety and fatigue
por: Austelle, Christopher, et al.
Publicado: (2021) -
Safety of transcutaneous auricular vagus nerve stimulation (taVNS): a systematic review and meta-analysis
por: Kim, Angela Yun, et al.
Publicado: (2022) -
No modulation of pupil size and event-related pupil response by transcutaneous auricular vagus nerve stimulation (taVNS)
por: Keute, Marius, et al.
Publicado: (2019)